Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

FDA Import Refusal Lawyer for Medley

The Town of Medley packs one of Florida’s heaviest concentrations of industrial land into a few square miles along the upper Miami River. Its warehouses feed South Florida’s grocery shelves, restaurant kitchens and bar programs, and its river terminals work shallow-draft cargo services from the Caribbean — much of it food, beverage and consumer products under FDA and TTB jurisdiction. That concentration of regulated commerce is why Garg Law brings its FDA and customs practice to Medley businesses from a Miami office on Brickell Avenue — close enough to the port, the airport and the agencies to act the day a problem surfaces. Between river-terminal entries and truck-borne transfers from the airport and seaport, Medley businesses sit squarely in the path of FDA and CBP enforcement activity.

Understanding FDA import refusals

Refusal is the end-stage of FDA’s admissibility process under section 801(a) of the Food, Drug, and Cosmetic Act. After a detention, if no testimony is submitted, the testimony fails, or a reconditioning attempt does not succeed, FDA issues a refusal of admission. CBP then supervises the required exportation or destruction of the merchandise, generally within 90 days.

Refusals carry consequences beyond the lost shipment. They become part of the compliance history FDA screens against — raising examination rates for future entries — and a pattern of refusals is the classic path onto an import alert. Redelivery demands and liquidated-damages claims from CBP can follow when refused goods were conditionally released and are not returned on time.

Where a refusal has not yet issued, aggressive use of the detention window — testimony, private laboratory evidence, or a reconditioning plan on FDA Form 766 — remains the best play. Where it has, options still exist: export for sale in other markets, contesting liquidated damages, and building the corrective record that keeps one refusal from becoming a standing problem.

Acting early vs. waiting: what it costs

Beyond losing the goods, an unmanaged refusal invites cascading costs — storage through the export window, CBP penalty claims, and a screening history that slows every subsequent shipment. For repeat importers, the record matters more than the load.

The engagement, step by step

  1. Immediate triage: where the entry stands between detention, refusal and CBP redelivery, and what deadlines remain
  2. Where possible, a testimony or reconditioning submission aimed at heading off the refusal
  3. After refusal: managing supervised export or destruction to minimize cost and preserve resale value abroad
  4. Defense against CBP liquidated-damages claims tied to the refused entry
  5. Root-cause corrective actions and documentation to protect your screening profile on future entries

Five mistakes that sink these matters

  • Abandoning the goods without a compliant export or destruction, triggering CBP claims
  • Missing the export window and losing salvage value entirely
  • Failing to contest inflated liquidated-damages assessments
  • Re-importing the same non-compliant product and building an import-alert record
  • Never diagnosing why the refusal happened, so it happens again

FDA Import Refusal Lawyer services for Medley

The work around Medley — food and beverage warehousing, wine, spirits and beer distribution, river-terminal cargo, building materials, wholesale distribution — is FDA-regulated at nearly every turn, and matters here move on the Miami River’s upper industrial reach along NW South River Drive, between the Palmetto Expressway and the Turnpike. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.

Frequently asked questions

Can an FDA refusal of admission be appealed?

There is no formal appeal once refusal issues; the meaningful opportunity is the detention stage. In limited circumstances FDA will reconsider — for example where the refusal rests on documented error — but the practical remedies are export, destruction and protecting the next entry.

What is the deadline to export refused goods?

Generally 90 days from the refusal, under CBP supervision. Blowing the window can convert the merchandise to government custody for destruction and expose the importer and surety to liquidated damages under the entry bond.

Can refused products be sold in another country?

Often yes — a U.S. refusal is not a global ban. Export must follow CBP supervision requirements, and destination-market rules apply, but supervised export for resale is frequently the best value-recovery path.

Why did I get a liquidated-damages notice after a refusal?

If goods were conditionally released and FDA later refused them, CBP may demand redelivery; failure to redeliver on time breaches the entry bond. These claims are frequently reducible through petition — they should not simply be paid at face value.

Will one refusal put me on an import alert?

Usually not by itself — but refusals are the raw material of import-alert listings. One refusal with a documented corrective response reads very differently to FDA than one of several unexplained ones.

Related services

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.